Fulgent Genetics (NASDAQ:FLGT) will release its quarterly earnings report on Friday, 2025-08-01. Here’s a brief overview for investors ahead of the announcement.
Analysts anticipate Fulgent Genetics to report an earnings per share (EPS) of $-0.33.
Investors in Fulgent Genetics are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Historical Earnings Performance
During the last quarter, the company reported an EPS beat by $0.22, leading to a 0.0% drop in the share price on the subsequent day.
Here’s a look at Fulgent Genetics’s past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -0.12 | -0.15 | -0.30 |
| EPS Actual | 0.04 | 0.04 | 0.31 | 0.15 |
| Price Change % | 19.0% | -2.0% | -12.0% | 6.0% |
Performance of Fulgent Genetics Shares
Shares of Fulgent Genetics were trading at $17.49 as of July 30. Over the last 52-week period, shares are down 30.36%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analyst Insights on Fulgent Genetics
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Fulgent Genetics.
Analysts have provided Fulgent Genetics with 2 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $24.0, suggesting a potential 37.22% upside.
Analyzing Ratings Among Peers
The …